ARS Pharmaceuticals (SPRY) Invested Capital (2020 - 2021)
ARS Pharmaceuticals (SPRY) reported Invested Capital of $495000.0 for Q1 2021, down 41.35% sequentially from $844000.0 in Q4 2020.
ARS Pharmaceuticals (SPRY) Invested Capital (2020 - 2021) Analysis & Trends
ARS Pharmaceuticals (SPRY) has 2 years of Invested Capital data on file, last reported at $495000.0 in Q1 2021.
- For the quarter ending Q1 2021, Invested Capital changed N/A year-over-year to $495000.0; the trailing twelve-month figure through Dec 2021 stood at $495000.0 (down 41.35% YoY), and the FY2020 full-year result was $844000.0, changed N/A from the prior year.
- Invested Capital declined to $495000.0 in Q1 2021, from $844000.0 in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $844000.0 in Q4 2020 to a low of $495000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 116.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | ARS Pharmaceuticals | 595.78 Mn | 394.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 495,000.00 |
| Dec 31, 2020 | 844,000.00 |